NCT02152943 2020-12-19Everolimus, Letrozole and Trastuzumab in HR- and HER2/Neu-positive PatientsM.D. Anderson Cancer CenterPhase 1 Completed37 enrolled
NCT01434303 2019-05-20Entinostat, Lapatinib Ditosylate and Trastuzumab in Treating Patients With Locally Recurrent or Distant Relapsed Metastatic Breast Cancer Previously Treated With Trastuzumab OnlyNational Cancer Institute (NCI)Phase 1 Completed37 enrolled